GlaxoSmithKline Expands into China with Nanjing MeiRui Pharma Acquisition

By Heather Cartwright

Pharma Deals Review: Vol 2010 Issue 10 (Table of Contents)

Published: 30 Dec-2010

DOI: 10.3833/pdr.v2010.i10.1415     ISSN: 1756-7874

Section: Mergers & Acquisitions

Fulltext:

Abstract

GlaxoSmithKline (GSK) has acquired the Chinese pharmaceutical company Nanjing MeiRui Pharma for approximately US$70 M in cash, emphasising its focus on emerging markets...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details